10% Owner of SANGAMO THERAPEUTICS, INC (U.S.: Nasdaq:SGMO), Biogen Inc., sells 28,884 shares worth $248,434

According to SANGAMO THERAPEUTICS, INC's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 30 04:20 PM, company 10% Owner, Biogen Inc. disclosed selling 28,884 shares at a cost of $8.60. At the time of this transaction (Nov 26), this trade was worth $248,434 in total. As of Nov 26, Biogen Inc. now owns 24,391,273 shares in total worth about $194,886,271.27.

For the last few recent trades made by SANGAMO THERAPEUTICS, INC (U.S.: Nasdaq:SGMO) 10% Owner, Biogen Inc., we have the following information:

Posted by George Daniels on Tuesday November 30 2021, 10:33 PM EST. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0